Abstract:Gap junctions form the cell-to-cell pathways for propagation of the precisely orchestrated patterns of current flow that govern the regular rhythm of the healthy heart. As in most tissues and organs, multiple connexin types are expressed in the heart: connexin43 (Cx43), Cx40 and Cx45 are found in distinctive combinations and relative quantities in different, functionally-specialized subsets of cardiac myocyte. Mutations in genes that encode connexins have only rarely been identified as being a cause of human cardiac disease, but remodelling of connexin expression and gap junction organization are well documented in acquired adult heart disease, notably ischaemic heart disease and heart failure. Remodelling may take the form of alterations in (i) the distribution of gap junctions and (ii) the amount and type of connexins expressed. Heterogeneous reduction in Cx43 expression and disordering in gap junction distribution feature in human ventricular disease and correlate with electrophysiologically identified arrhythmic changes and contractile dysfunction in animal models. Disease-related alterations in Cx45 and Cx40 expression have also been reported, and some of the functional implications of these are beginning to emerge. Apart from ventricular disease, various features of gap junction organization and connexin expression have been implicated in the initiation and persistence of the most common form of atrial arrhythmia, atrial fibrillation, though the disparate findings in this area remain to be clarified. Other major tasks ahead focus on the Purkinje/working ventricular myocyte interface and its role in normal and abnormal impulse propagation, connexin-interacting proteins and their regulatory functions, and on defining the precise functional properties conferred by the distinctive connexin co-expression patterns of different myocyte types in health and disease.

Connexin Mutations and Hereditary Diseases

Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43

Cellular and Deafness Mechanisms Underlying Connexin Mutation-Induced Hearing Loss – A Common Hereditary Deafness

Pathological mechanisms of connexin26-related hearing loss: Potassium recycling, ATP-calcium signaling, or energy supply?

Connexin Hemichannels in Astrocytes: Role in CNS Disorders

Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease

Remodelling of gap junctions and connexin expression in diseased myocardium

Simulation-predicted and -explained inheritance model of pathogenicity confirmed by transgenic mice models

Connexin Mutants and Cataracts

Evaluating the role of connexin 43 in congenital heart disease : and the analysis of knockin mouse models

GJB1-associated X-linked Charcot–Marie–Tooth disease, a disorder affecting the central and peripheral nervous systems

Functional analysis and regulation of purified connexin hemichannels

Connexin 43 Phosphorylation: Implications in Multiple Diseases

Identification And Preliminary Functional Analysis Of Two Novel Congenital Cataract Associated Mutations Of Cx46 And Cx50

Cytoskeleton-associated protein in the inner ear and gene mutations cause hereditary deafness

New insights into the expression and function of neural connexins with transgenic mouse mutants

Gap-junctional channel and hemichannel activity of two recently identified connexin 26 mutants associated with deafness

Connexin Hemichannel Inhibition and Human Genodermatoses

Mutant Connexin 32 Abnormally Distributed in the Vascular Endothelial Cells of X-linked Charcot-Marie-Tooth Disease Type 1 Patients

Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf.

Mutations of CX46/CX50 and Cataract Development